CLINICAL_TRIALS
trial_result
· 2017-03-22
Clinical Trial Update: Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation [Phase 2]
Summary
Elobixibat (A3309) was studied in a Phase 2 trial for chronic idiopathic constipation; the study completed and results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Albireo | Conditions: Constipation, Chronic Constipation | Phase 2 | Status: COMPLETED | Results posted: 2017-03-22